Stay updated with breaking news from Nasdaq Bcab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price […]
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,780,000 shares, a growth of 16.7% from the April 15th total of 3,240,000 shares. Based on an average daily trading volume, of 512,800 shares, the short-interest ratio is […]
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have received a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that […]
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) has been given an average rating of “Moderate Buy” by the six ratings firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target […]
Formidable Asset Management LLC lowered its position in shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) by 16.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,607 shares of the company’s stock after selling 6,813 shares during the […]